Programme at a glance

Programme at a glance, Paris

Thursday, 4 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
14.30 - 17.00
Auditorium A
Actualités et controverses sur l’arthrose et l’ostéoporose
‣ Symposium conjointement organisé par la Société Française de Rhumatologie (SFR), le Groupe de Recherche et d’Informations sur les Ostéoporoses (GRIO), l’International Osteoporosis Foundation (IOF) et l’European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Leith Zakraoui, ‣ Bernard Cortet, ‣ Thierry Thomas
‣ 14h30 : Produits laitiers fermentés et santé osseuse Emmanuel Biver
‣ 14h55 : L’arthrose, une histoire d’alimentation ? Jérémie Sellam
‣ 15h20 : L’arthrose, une maladie inflammatoire ? Florent Eymard
‣ 15h45 : Vitamine D, arthrose et ostéoporose Etienne Cavalier
‣ 16h10 : L’arthrose rachidienne existe-t-elle ? François Rannou
‣ 16h35 : La place de la vertébroplastie, les données sont-elles solides ? Bernard Cortet
‣ 17h00 : Conclusion Thierry Thomas

Symposium organisé en langue française.

17.45 - 20.00
Auditorium A
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: ‣ John A. Kanis, ‣ Jean‑Yves Reginster
17.45
Auditorium A
Best clinical papers published in 2018
‣ René Rizzoli
18.30
Auditorium A
Beyond nutrients: health effects of the dairy matrix
‣ Arne Astrup
19.00
Auditorium A
2018 update of the European guidelines for the diagnosis and management of osteoporosis (ESCEO-IOF)
‣ René Rizzoli
19.15
Auditorium A
Plenary Lecture: Disease in Art Painting
‣ Davide Lazzeri
19.45
Auditorium A
Opening of the meeting
‣ Cyrus Cooper (IOF President, ESCEO Vice‑President)
19.50
Auditorium A
Presentation of the 2019 ESCEO Medal of Excellence
‣ Jean‑Yves Reginster
19.50
Auditorium A
Presentation of the IOF Olof Johnell Science Award
‣ Cyrus Cooper
Friday, 5 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
SYMPOSIA
Meeting Room 342A
Patients' preferences for anti-osteoarthritis treatment: A cross-European Discrete Choice Experiment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Mickaël Hiligsmann, ‣ Elaine M. Dennison
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification prioritization of important attributes of OA treatment Elaine M. Dennison
‣ 08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann
‣ 08:35: Discussion Elaine M. Dennison
‣ 08:55: Conclusion Mickaël Hiligsmann
Meeting Room 351
Osteosarcopenic obesity: enough evidence for a distinct entity: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Roger Fielding
‣ 08:00: Introduction Stefania Maggi
‣ 08:05: Osteosarcopenic obesity: Facts and evidence supporting a distinct entity Jürgen Bauer
‣ 08:20: Osteosarcopenic obesity: Lack of evidence supporting a distinct entity Alfonso Cruz Jentoft
‣ 08:35: Discussion Jürgen Bauer
‣ 08:55: Conclusion Roger Fielding
Panel: ‣ Islene Araujo de Carvalho, ‣ Jürgen Bauer, ‣ Olivier Bruyère, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Elaine M. Dennison, ‣ Roger Fielding, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Francesco Landi, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Stefania Maggi, ‣ Eugene McCloskey, ‣ Simone Perna, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Yves Rolland, ‣ Pawel Szulc
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 341
What’s new in tendinopathies?
Chairperson: ‣ Jean‑François Kaux
‣ Introduction Olivier Bruyère
‣ Tendon physiopathology and imagery... What’s new ? Stijn Bogaerts
‣ Rehabilitation: eccentric or not eccentric? Which physiotherapy? Jean‑Louis Croisier
‣ Which efficacy for the new treatments ? Jean‑François Kaux
Meeting Room 352A
Real World Evidence in Metabolic Bone Disease
Chairperson: ‣ Daniel Prieto‑Alhambra
‣ Real world data for assessing the use, risks, and benefits of anti-osteoporosis therapies in actual practice conditions Daniel Prieto‑Alhambra
‣ Routinely collected data for the study of the epidemiology of fractures, and for characterising imminent fracture risk Bo Abrahamsen
‣ Health economics using real world data: an introduction Rafael Pinedo‑Villanueva
‣ Real world data for the study of orthopaedics and hip fracture care Alma Pedersen
Meeting Room 353
Emerging Biomarkers in Vitamin D Metabolism
Chairperson: ‣ Shaun Sabico
‣ Biomarker Discovery Nasser Al‑Daghri
‣ Vitamin D Biomarker Discovery Majed Alokail
‣ Validation Yousef  Al‑Saleh
Meeting Room 343
Sarcopenia in older people: actual perspectives
Chairpersons: ‣ Nicola Veronese, ‣ Charlotte Beaudart
‣ The radiological evaluation of muscle mass in older people Giuseppe Guglielmi
‣ Physical performance in older people: actual evidence Olivier Bruyère
‣ The diagnosis of sarcopenia in older people: between research and clinical practice Nicola Veronese
Meeting Room 342B
Female Bone Health: a gynecological approach through routine assistance
Chairperson: ‣ Adriana Orcesi Pedro
‣ Opening: Women´s Hospital - CAISM - University of Campinas message for bone health Adriana Orcesi Pedro
‣ Bone mass and fracture risk during pregnancy and lactation Anna V. Gueldini de Moraes, Fernanda Garanhani de Castro Surita
‣ Update on management of osteoporosis in young women - special clinical situations Adriana Orcesi Pedro, Gabriela Pravatta Rezende
‣ Evaluation and management of osteopenia and osteoporosis in breast cancer survivors Adriana Orcesi Pedro, Cesar Cabello dos Santos
‣ Question & Answers with audience
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
09.00
Auditorium A
Plenary Lecture 1
‣ When and why use a bone forming agent?
‣ Eugene McCloskey
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC1
‣ HORMONE THERAPY REDUCES THE RISK OF FRACTURE IN FALLERS AND IN NON-FALLERS: RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS
Presenting author: ‣ M. Lorentzon
Authors: ‣ H. Johansson, ‣ N. C. Harvey, ‣ E. Liu, ‣ J. Crandall, ‣ E. V. McCloskey, ‣ J. A. Kanis
09.40
Auditorium A
OC2
‣ ROMOSOZUMAB EFFICACY ON FRACTURE OUTCOMES IS GREATER IN PATIENTS AT HIGH BASELINE FRACTURE RISK: A POST HOC ANALYSIS OF THE FRAME STUDY
Presenting author: ‣ E. V. McCloskey
Authors: ‣ M. Lorentzon, ‣ H. Johansson, ‣ N. C. Harvey, ‣ J. A. Kanis
09.50
Auditorium A
OC3
‣ ROMOSOZUMAB ENHANCES 3D VERTEBRAL STRUCTURE IN WOMEN WITH LOW BONE DENSITY: MAPPING BONE GAINS AT ONE YEAR COMPARED WITH TERIPARATIDE OR PLACEBO
Presenting author: ‣ K. E. S. Poole
Authors: ‣ G. M. Treece, ‣ R. A. Pearson, ‣ A. H. Gee, ‣ M. A. Bolognese, ‣ J. P. Brown, ‣ S. Goemaere, ‣ A. Grauer, ‣ D. A. Hanley, ‣ C. Mautalen, ‣ C. Recknor, ‣ Y. C. Yang, ‣ C. Libanati, ‣ T. Whitmarsh
10.00
Auditorium A
OC4
‣ EFFECT OF ABALOPARATIDE ON BONE MINERAL DENSITY AND FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOARTHRITIS
Presenting author: ‣ N. E. Lane
Authors: ‣ B. Mitlak, ‣ R. Weiss, ‣ Y. Wang, ‣ G. J. Valenzuela, ‣ J. P. Bilezikian
10.10
Auditorium A
OC5
‣ BUROSUMAB IMPROVES THE BIOCHEMICAL, SKELETAL, AND CLINICAL SYMPTOMS OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
Presenting author: ‣ S. Jan de Beur
Authors: ‣ P. Miller, ‣ T. Weber, ‣ M. Peacock, ‣ K. Insogna, ‣ R. Kumar, ‣ D. Luca, ‣ T. Cimms, ‣ K. Lampl, ‣ J. San Martin, ‣ T. Carpenter
10.20
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
‣ Jean‑Yves Reginster
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: ‣ René Rizzoli, ‣ Cyrus Cooper
10.30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
‣ René Rizzoli
10.40
Auditorium A
Plenary Lecture 2
‣ Bone fragility and its treatment in chronic renal failure
‣ Peter R. Ebeling
11.10
Auditorium A
Presentation of the IOF President's Award
‣ Cyrus Cooper
11.20
Auditorium A
Oral communication selected from abstracts
11.20
Auditorium A
OC6
‣ IMMINENT (1- AND 2-YEAR) FRACTURE RISK FOLLOWING A FIRST (SENTINEL) FRACTURE: A MULTINATIONAL EUROPEAN COHORT STUDY INCLUDING OVER 700,000 PARTICIPANTS FROM DENMARK, SPAIN, AND THE UK
Presenting author: ‣ D. Prieto‑Alhambra
Authors: ‣ S. Khalid, ‣ M. Thomsen Ernst, ‣ M. K. Javaid, ‣ C. Libanati, ‣ C. Cooper, ‣ A. Delmestri, ‣ D. Martinez‑Laguna, ‣ E. Toth, ‣ B. Abrahamsen
11.30
Auditorium A
OC7
‣ ADJUSTING FRAX FOR IMMINENT RISK
Presenting author: ‣ H. Johansson
Authors: ‣ K. Siggeirsdottir, ‣ N. C. Harvey, ‣ E. V. McCloskey, ‣ V. Gudnason, ‣ G. Sigurdsson, ‣ M. Lorentzon, ‣ E. Liu, ‣ J. A. Kanis
11.40
Auditorium A
OC8
‣ AGE AT HIP FRACTURE: TIME TRENDS OVER TWO DECADES IN A NATIONAL HOSPITAL DISCHARGE REGISTER
Presenting author: ‣ B. Abrahamsen
Authors: ‣ H. V. B. Laursen, ‣ M. K. Skjødt, ‣ M. H. Jensen, ‣ P. Vestergaard
11.50
Auditorium A
OC9
‣ T-SCORE AS AN INDICATOR OF FRACTURE RISK ON THERAPY: EVIDENCE FROM ROMOSOZUMAB VS. ALENDRONATE TREATMENT IN THE ACTIVE-CONTROLLED FRACTURE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK TRIAL
Presenting author: ‣ S. Ferrari
Authors: ‣ F. Cosman, ‣ E. M. Lewiecki, ‣ P. R. Ebeling, ‣ E. Hesse, ‣ N. Napoli, ‣ D. B. Crittenden, ‣ M. Rojeski, ‣ W. Yang, ‣ C. Libanati
12.00
Auditorium A
OC10
‣ FRACTURE INCIDENCE AFTER DENOSUMAB DISCONTINUATION: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
Presenting author: ‣ L. Tripto‑Shkolnik
Authors: ‣ N. Fund, ‣ V. Rouach, ‣ G. Chodick, ‣ V. Shalev, ‣ I. Goldshtein
13.45 - 14.00
Podium
IOF Calcium Academy Awards ceremony
‣ Bess Dawson‑Hughes
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 341
How to assess frailty in daily practice ?
‣ Evelien Gielen
Meeting Room 352A
Local therapies in osteoarthritis management
‣ François Rannou
Meeting Room 353
Pre- and postnatal influences on bone and muscle health in children
‣ Nicholas Harvey
Meeting Room 343
Strengths of recommendations for GIOP management
‣ Jonathan Adachi
Meeting Room 342B
New algorithm for the management of bone fragility in diabetes
‣ Serge Ferrari
14.00 - 15.00
SYMPOSIA
Meeting Room 342A
Reassessment of the safety of anti-osteoarthritis medications: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Olivier Bruyère, ‣ Elaine M. Dennison
‣ 14:00: Welcome and scope of the problem Cyrus Cooper
‣ 14:05: Methodology of the ESCEO Working Group Cyrus Cooper
‣ 14:15: Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids Nicholas R. Fuggle
‣ 14:30: Safety of SYSADOAs, intraarticular Hyaluronic Acid and intraarticular corticosteroids Tim McAlindon
‣ 14:45: Discussion Nigel K. Arden
‣ 14:55: Wrap-up and conclusions Nigel K. Arden
Meeting Room 351
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: outcomes of an ESCEO-IOF experts consensus meeting organized under the auspices of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Stefania Maggi
‣ 14:00: Welcome and scope of the problem Maria Luisa Brandi
‣ 14:05: Determinants of non-adherence to anti-osteoporosis medications Bernard Vrijens
‣ 14:20: Recommendations to improve adherence to anti-osteoporosis medications Mickaël Hiligsmann
‣ 14:35: Recommendations for additional research needed to improve adherence to anti-osteoporosis medications Bo Abrahamsen
‣ 14:45: Discussion (Leader : Sansin Tuzun)
‣ 15:00: Closure of the meeting Adolfo Diez‑Perez
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: ‣ Tara Brennan‑Speranza
14.00
Podium
P893
‣ IDENTIFICATION OF PATIENTS AT HIGH RISK FOR OSTEOPOROTIC FRACTURES THROUGH RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS): RESULTS OF A 5-YEAR FOLLOW-UP STUDY
Presenting author: ‣ C. Caffarelli
Authors: ‣ S. Gonnelli, ‣ G. Bianchi, ‣ M. L. Brandi, ‣ S. Casciaro, ‣ L. Cavalli, ‣ L. Cianferotti, ‣ F. Conversano, ‣ A. Fassio, ‣ G. Girasole, ‣ A. Grimaldi, ‣ F. A. Lombardi, ‣ M. Muratore, ‣ P. Pisani, ‣ L. Quarta, ‣ D. Gatti
14.07
Podium
P927
‣ PATIENT AND SERVICE-LEVEL PREDICTORS OF BONE TREATMENT RECOMMENDATION POST-FRACTURE: RESULTS FROM THE UK NATIONAL FRACTURE LIAISON SERVICE (FLS) DATABASE
Presenting author: ‣ M. K. Javaid
Authors: ‣ S. Hawley, ‣ N. Vasilakis, ‣ B. Wiles, ‣ C. L. Gregson, ‣ N. Gittoes, ‣ G. Clunie, ‣ C. Cockill, ‣ I. Price, ‣ A. Judge, ‣ A. Smith
14.14
Podium
P363
‣ FRAILTY IN OLDER COMMUNITY DWELLING ADULTS: A COMPARATIVE STUDY OF THE UK AND JAPAN
Presenting author: ‣ N. Yoshimura
Authors: ‣ E. M. Dennison, ‣ K. A. Jameson, ‣ S. Tanaka, ‣ T. Iidaka, ‣ C. Cooper
14.21
Podium
P154
‣ EWGSOP 2 VERSUS EWGSOP 1: IMPACT ON THE PREVALENCE OF SARCOPENIA AND ITS OUTCOMES
Presenting author: ‣ M. Locquet
Authors: ‣ C. Beaudart, ‣ J. Petermans, ‣ O. Bruyère
14.28
Podium
P639
‣ DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS IS A NEW RISK FACTOR FOR VERTEBRAL FRACTURE IN OLDER MEN – THE PROSPECTIVE MINOS STUDY
Presenting author: ‣ P.  Szulc
Authors: ‣ A. Guiot, ‣ R. D. Chapurlat
14.35
Podium
P837
‣ FOR ALL PRACTITIONERS AND RESEARCHERS TO ASSESS HAND DYSFUNCTION IN HAND OSTEOARTHRITIS (OA): THE QUICK, FRIENDLY AND AVAILABLE FOR FREE FUNCTIONAL INDEX FOR HAND OA WEBSITE FIHOA.NET
Presenting author: ‣ E. Maheu
Author: ‣ R.‑L. Dreiser
14.42
Podium
P586
‣ IMMINENT FRACTURE RISK AMONGST NEW USERS OF ORAL BISPHOSPHONATES IN ACTUAL PRACTICE SETTINGS: A MULTI-NATIONAL EUROPEAN COHORT STUDY FROM DENMARK, SPAIN, AND THE UK
Presenting author: ‣ D. Prieto‑Alhambra
Authors: ‣ S. Khalid, ‣ M. Thomsen Ernst, ‣ M. K. Javaid, ‣ C. Libanati, ‣ C. Cooper, ‣ A. Delmestri, ‣ D. Martinez‑Laguna, ‣ E. Toth, ‣ B. Abrahamsen
14.49
Podium
P701
‣ RISK OF HAND OSTEOARTHRITIS IN NEW USERS OF HORMONE REPLACEMENT THERAPY: A NESTED CASE-CONTROL ANALYSIS
Presenting author: ‣ T. Burkard
Authors: ‣ M. Rauch, ‣ J. Spoendlin, ‣ D. Prieto‑Alhambra, ‣ S. S. Jick, ‣ C. R. Meier
14.56
Podium
P1041
‣ CAN WE AVOID THE LOSS OF BONE MINERAL DENSITY ONE YEAR AFTER DENOSUMAB DISCONTINUATION? THE REOLAUS BONE PROJECT
Presenting author: ‣ B. Aubry‑Rozier
Authors: ‣ G. Liebich, ‣ D. Stoll, ‣ E. Gonzalez‑Rodriguez, ‣ D. Hans, ‣ O. Lamy
15.03
Podium
P698
‣ MAJOR OSTEOPOROTIC FRACTURE RISK FOLLOWING BARIATRIC SURGERY: A SELF-CONTROLLED CASE SERIES INCLUDING 5,492 PEOPLE FROM THE UK CPRD AND LINKED HES DATABASES
Presenting author: ‣ D. E. Robinson
Authors: ‣ I. Douglas, ‣ G. D. Tan, ‣ C. Cooper, ‣ A. Delmestri, ‣ M. K. Javaid, ‣ A. Judge, ‣ V. Y. Strauss, ‣ D. Prieto‑Alhambra
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: ‣ Charlotte Beaudart, ‣ Bess Dawson‑Hughes
15.00
Auditorium A
Plenary Lecture 3
‣ Early treatment of osteoarthritis
‣ Nigel K. Arden
15.30
Auditorium A
Oral communication selected from abstracts
15.30
Auditorium A
OC11
‣ CARDIOVASCULAR COMORBIDITIES HAS A DELETERIOUS INFLUENCE ON KNEE OA PROGNOSIS AT 5 YEARS: DATA FROM THE PROSPECTIVE KHOALA COHORT
Presenting author: ‣ C. Roubille
Authors: ‣ J. Joel, ‣ S. Sellam, ‣ A. C. Rat, ‣ F.  Guillemin, ‣ C. Roux
15.40
Auditorium A
OC12
‣ PREVALENCE OF SARCOPENIA ACCORDING TO THE REVISED EWGSOP DEFINITION AND ITS ASSOCIATIONS WITH BONE STRUCTURE AND INCIDENT FALLS IN SWEDISH OLDER ADULTS
Presenting author: ‣ D. Scott
Authors: ‣ J. Johansson, ‣ L. Mcmillan, ‣ P. R. Ebeling, ‣ P. Nordstrom, ‣ A. Nordstrom
15.50
Auditorium A
OC13
‣ STRENGTH AND PERFORMANCE-BASED OPERATIONAL MEASURES OF SARCOPENIA: PREVALENCE AND ASSOCIATIONS WITH SOCIAL FACTORS AND PHYSICAL DISABILITY IN 10,461 ADULTS AGED 65 YEARS AND OVER FROM SIX LOWER- AND MIDDLE-INCOME COUNTRIES
Presenting author: ‣ S. L. Brennan‑Olsen
Authors: ‣ S. J. Bowe, ‣ P. Kowal, ‣ J. Gaskin, ‣ N. Naidoo, ‣ J. Snodgrass, ‣ T. Quashie, ‣ S. Agrawal, ‣ G. Eick, ‣ C. D'Este
16.00
Auditorium A
OC14
‣ WHICH MUSCLE PARAMETERS ARE LONGITUDINALLY ASSOCIATED WITH FUTURE KNEE OSTEOARTHRITIS OUTCOMES? FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ N. R. Fuggle
Authors: ‣ L. D. Westbury, ‣ K. A. Jameson, ‣ H. E. Syddall, ‣ M. H. Edwards, ‣ K. A. Ward, ‣ E. M. Dennison, ‣ C. Cooper
16.10
Auditorium A
OC15
‣ PATIENT ENGAGEMENT IN CLINICAL GUIDELINES DEVELOPMENT: INPUT FROM >1000 MEMBERS OF THE CANADIAN OSTEOPOROSIS PATIENT NETWORK
Presenting author: ‣ L. Funnell
Authors: ‣ M. Djekic‑Ivankovic, ‣ R. Chepesiuk, ‣ L. Giangregorio, ‣ I. Braganca Rodrigues, ‣ R. Ridout, ‣ S. Feldman, ‣ S. Kim, ‣ H. Mcdonald‑Blumer, ‣ G. Kline, ‣ W. E. Ward, ‣ N. Santesso, ‣ W. D. Leslie, ‣ S. N. Morin
16.20
Auditorium A
OC16
‣ RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER BARIATRIC SURGERY IN FRANCE: POPULATION BASED, RETROSPECTIVE COHORT STUDY
Presenting author: ‣ J. Paccou
Authors: ‣ N. Martignène, ‣ E. Lespessailles, ‣ G. Babykina, ‣ B. Cortet, ‣ G. Ficheur
16.30
Auditorium A
Plenary Lecture 4
‣ Guidelines for the management of osteoarthritis
‣ Jean‑Yves Reginster
15.00 - 16.45
Meeting Room 351
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures
Chairpersons: ‣ Jean‑Yves Reginster, ‣ Famida Jiwa, ‣ Philippe Halbout
15.03
Meeting Room 351
OCs1
‣ DETERMINANTS AND HEALTH CONSEQUENCES OF A RAPID MUSCLE HEALTH DECLINE IN OLDER ADULTS FROM THE SARCOPHAGE STUDY
Presenting author: ‣ M. Locquet
Authors: ‣ C. Beaudart, ‣ J.‑L. Croisier, ‣ J.‑Y. Reginster, ‣ O. Bruyère
15.11
Meeting Room 351
OCs2
‣ THE ASSOCIATION BETWEEN RESTING METABOLIC RATE (RMR) AND SARCOPENIC OBESITY (SO) IN OVERWEIGHT AND OBESE ADULT WOMEN
Presenting author: ‣ K. Mirzaei
Authors: ‣ N. Rasaei, ‣ S. F. Sajjadi, ‣ S. A. Keshavarz
15.19
Meeting Room 351
OCs3
‣ WILL THERE BE A FRACTURE IN THEIR FUTURE? BONE MINERAL DENSITY FINDINGS IN YOUNG SOUTH EAST ASIAN WOMEN WITH ANOREXIA NERVOSA
Presenting author: ‣ M. Chandran
Author: ‣ Y. Hao
15.27
Meeting Room 351
OCs4
‣ THE BENEFITS OF REGULAR WEIGHT BEARING ACTIVITY THROUGHOUT THE LIFE-COURSE: DO MEN AND WOMEN REAP THE SAME REWARDS?
Presenting author: ‣ J. Zhang
Authors: ‣ M. A. Clynes, ‣ K. A. Jameson, ‣ C. Cooper, ‣ E. M. Dennison
15.35
Meeting Room 351
OCs5
‣ ASSOCIATION OF 25-HYDROXY VITAMIN D WITH BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN AN IRANIAN ELDERLY POPULATION: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: ‣ S. Gharibzadeh
Authors: ‣ N. Fahimfar, ‣ G. Shafiee, ‣ R. Heshmat, ‣ N. Mehrdad, ‣ F. Razi, ‣ P. Khashayar, ‣ A. Raiesi, ‣ I. Nabipour, ‣ B. Larijani, ‣ A. Ostovar
15.45
Meeting Room 351
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster
15.55
Meeting Room 351
OCs6
‣ SERUM VITAMIN D LEVEL ASSOCIATED WITH COGNITIVE AND PHYSICAL FUNCTIONING OF POSTMENOPAUSAL WOMEN
Presenting author: ‣ A. A. Popov
Authors: ‣ N. V. Izmozherova, ‣ E. A. Safianik, ‣ A. A. Vikhareva, ‣ V. M. Bakhtin, ‣ M. A. Shambatov
16.03
Meeting Room 351
OCs7
‣ POSTPARTUM OSTEOPOROSIS ASSOCIATED WITH VERTEBRAL FRACTURES
Presenting author: ‣ N. Temelkova
Authors: ‣ A. Gerganova, ‣ K. Temelkova, ‣ K. Sirakova, ‣ P. Popivanov
16.11
Meeting Room 351
OCs8
‣ VALIDATION OF THE FRACTURE RISK ASSESSMENT TOOL (FRAX) CALCULATOR IN TAIWAN-TWO COHORTS STUDY
Presenting author: ‣ W.‑C. Hung
Authors: ‣ C. H. Wu, ‣ F. W. Liang, ‣ I. T. Liu, ‣ Y. F. Chang, ‣ L. C. Ou, ‣ C. S. Chang, ‣ T. H. Lu
16.19
Meeting Room 351
OCs9
‣ PREVALENCE OF SARCOPENIA IN INDIAN MEN AND WOMEN VARIES ACCORDING TO THE DEFINITION USED
Presenting author: ‣ A. Zengin
Authors: ‣ B. Kulkarni, ‣ A. V. Khadilkar, ‣ V. Ekbote, ‣ N. Kajale, ‣ N. Tandon, ‣ S. K. Bhargava, ‣ H. P. S. Sachdev, ‣ S. Sinha, ‣ C. H. D. Fall, ‣ P. R. Ebeling
16.27
Meeting Room 351
OCs10
‣ VERTEBRAL PAIN AND PHYSICAL PERFORMANCE INDICES IN POSTMENOPAUSAL WOMEN WITH VERTEBRAL FRACTURES DEPENDING ON BONE MINERAL DENSITY PARAMETERS
Presenting author: ‣ N. Grygorieva
Authors: ‣ V. Povoroznyuk, ‣ O. Rybina
16.35
Meeting Room 351
OCs11
‣ FAMILY HISTORY INFLUENCES FRACTURE RISK BMD- INDEPENDENTLY
Presenting author: ‣ A. I. Gasparik
Authors: ‣ M. L. Cevei, ‣ D. Stoicanescu, ‣ T. Szocs
Saturday, 6 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Auditorium B
Osteosarcopenia: Elucidating bone, muscle and fat interactions
Chairperson: ‣ Gustavo Duque
‣ Osteosarcopenia: Where bone, muscle and fat collide Gustavo Duque
‣ Diagnostic approach to osteosarcopenia Alexandra Papaioannou
‣ Osteosarcopenia: Potential Therapeutic Interventions Liang‑Kung Chen
Meeting Room 341
Vitamin D: as viewed by the laboratory
Chairperson: ‣ Etienne Cavalier
‣ Vitamin D: Optimal levels Harjit Pal Bhattoa
‣ Vitamin D metabolites: Now and Beyond Etienne Cavalier
Meeting Room 352A
FLS in the UK 2014-2018: implementation, standards, quality improvement and benefits
Chairperson: ‣ Bo Abrahamsen
‣ FLS Implementation: An innovative service support model for secondary fracture prevention in the UK Will Carr
‣ Securing funding for service implementation and improvement - demonstrating the benefits and effectiveness of fracture liaison services Tim Jones
‣ Vertebral Fracture Identification – meeting the challenge of FLS standards Jill Griffin
Meeting Room 353
Non-pharmacological treatment of low back pain
Chairperson: ‣ Alexander Barulin
‣ Cognitive-behavioral therapy in the treatment of chronic back pain Olga Kurushina
‣ Biomechanical aspects for understanding of non-specific low-back pain Alexander Barulin
‣ Kinesiotaping in the correction of myofascial back pain Bogdan Kalinchenko
‣ New approaches to the correction of pain in patients with peripheral paralysis Olga Agarkova
Meeting Room 343
Learning on Common Diseases by Understanding the Rare Disorders: The Case of Bone Fragility
Chairperson: ‣ Maria Luisa Brandi
‣ Taxonomy of Metabolic Bone Diseases Laura Masi
‣ FD-MAS Guidelines Naveen Hamdy
‣ Hypophosphatasia in the adults Christian Roux
‣ Phosphate wasting disorders in the adults Kassim Javaid
Meeting Room 342B
Are current treatment recommendations for Osteoarthritis adapted to old/very old patients ?
Chairpersons: ‣ Emmanuel Maheu, ‣ Odile Levy‑Reynaud
‣ How to manage NSAID in the Elderly in knee, hip or hand osteoarthritis treatment? Christian Cadet
‣ Are guidelines for the management of osteoarthritis adapted to very old patients: how to manage opioids in the Elderly in knee, hip or hand osteoarthritis? Odile Levy‑Reynaud
‣ Exercise and weight loss in the management of knee/hip OA in very old patients: current data and how to prescribe Jean‑Laurent Le Quintrec
‣ Total joint replacement of knee or hip in osteoarthritis management of very old patients, is it possible: current evidence and how to proceed? Emmanuel Maheu
08.00 - 09.00
SYMPOSIUM
Meeting Room 342A
Recommendations for the conduct of the economic evaluation in osteoporosis: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) USA branch
Chairpersons: ‣ Stuart Silverman, ‣ Mickaël Hiligsmann
‣ 08:00: Welcome and scope of the problem Stuart Silverman
‣ 08:05: Recommendations for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Mickaël Hiligsmann
‣ 08:25: Challenges, uncertainties and future research agenda for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Stuart Silverman
‣ 08:40: Discussion Panel
‣ 08:55: Conclusion Mickaël Hiligsmann
Panel: ‣ Susan Bukata, ‣ Philippe Halbout, ‣ Mickaël Hiligsmann, ‣ Famida Jiwa, ‣ Mike Lewiecki, ‣ Daniel Pinto, ‣ Jean‑Yves Reginster, ‣ Kenneth Saag, ‣ Stuart Silverman, ‣ Anna N. A. Tosteson
08.00 - 09.00
Meeting Room 351
EUGMS-ESCEO-IOF Symposium
‣ SARCOPENIA COMES OF AGE
Chairperson: ‣ Stefania Maggi
‣ What is new in the definition of sarcopenia? Alfonso Cruz Jentoft
‣ Diagnosing sarcopenia in clinical practice Yves Rolland
‣ Diet and exercise to treat sarcopenia Jürgen Bauer
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION IV
Chairpersons: ‣ Thierry Thomas, ‣ Stefania Maggi
09.00
Auditorium A
Plenary Lecture 5
‣ What spaceflight has taught us regarding bone and muscle
‣ Laurence Vico
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC17
‣ A MULTICENTER, RANDOMIZED, RATER-BLINDED, PARALLEL-GROUP, PHASE 3 STUDY TO COMPARE THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF BIOSIMILAR RGB-10 AND REFERENCE ONCE-DAILY TERIPARATIDE IN PATIENTS WITH PRIMARY OSTEOPOROSIS
Presenting author: ‣ H. Hagino
Authors: ‣ R. Narita, ‣ Y. Yokoyama, ‣ M. Watanabe, ‣ M. Tomomitsu
09.40
Auditorium A
OC18
‣ SKELETAL BENEFIT/RISK OF LONG-TERM DENOSUMAB (DMAB) THERAPY: A VIRTUAL TWIN ANALYSIS OF FRACTURES (FX) PREVENTED TO SKELETAL SAFETY EVENTS OBSERVED
Presenting author: ‣ S. Ferrari
Authors: ‣ E. M. Lewiecki, ‣ P. W. Butler, ‣ D. L. Kendler, ‣ N. Napoli, ‣ S. Huang, ‣ D. B. Crittenden, ‣ N. Pannacciulli, ‣ E. Siris, ‣ N. Binkley
09.50
Auditorium A
OC19
‣ THE EFFECT OF COMBINED TERIPARATIDE AND WHOLEBODY VIBRATION EXERCISE IN POSTMENOPAUSAL OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL
Presenting author: ‣ D. B. Jepsen
Authors: ‣ J. Ryg, ‣ S. Hansen, ‣ J. Gram, ‣ N. R. Jørgensen, ‣ T. Masud
10.00
Auditorium A
OC20
‣ EFFECTS OF A MULTINUTRIENT FORTIFIED DAIRY PRODUCT COMBINED WITH EXERCISE ON FUNCTIONAL MUSCLE PERFORMANCE, BODY COMPOSITION AND INFLAMMATION IN SEDENTARY MIDDLE AGED WOMEN: A 4-MONTH DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMIZED TRIAL
Presenting author: ‣ R. Daly
Authors: ‣ J. Gianoudis, ‣ B. De Ross, ‣ S. O'Connell, ‣ L. Schollum, ‣ C. Gunn
10.10
Auditorium A
OC21
‣ EFFECT OF ORAL CHONDROITIN SULFATE ON PAIN IN PATIENTS WITH KNEE OSTEOARTHRITIS: OUTCOMES OF A COMPREHENSIVE META-ANALYSIS EXPLORING INCONSISTENCIES IN RANDOMISED, PLACEBO-CONTROLLED TRIALS
Presenting author: ‣ G. Honvo
Authors: ‣ O. Bruyère, ‣ A. Geerinck, ‣ N. Veronese, ‣ J.‑Y. Reginster
10.20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
‣ Jean‑Yves Reginster
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION V
Chairpersons: ‣ Bernard Cortet, ‣ Elaine M. Dennison
10.30
Auditorium A
Presentation of the IOF Medal of Achievement
‣ Serge Ferrari
10.40
Auditorium A
Plenary Lecture 6
‣ Pharmacological agents for the treatment of sarcopenia
‣ Roger Fielding
11.10
Auditorium A
Oral communication selected from abstracts
11.10
Auditorium A
OC22
‣ DXA-BASED 3D ANALYSIS OF PROXIMAL FEMUR CORTICAL AND TRABECULAR BONE FOR FRACTURE RISK ASSESSMENT: A PROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN
Presenting author: ‣ E. Biver
Authors: ‣ M. Hars, ‣ R. Winzenrieth, ‣ R. Rizzoli, ‣ S. Ferrari
11.20
Auditorium A
OC23
‣ SARCOPENIA DEFINITIONS AS PREDICTORS OF FRACTURE RISK INDEPENDENT OF FRAX, FALLS AND BMD IN THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY: A META-ANALYSIS
Presenting author: ‣ N. C. Harvey
Authors: ‣ A. Odén, ‣ E. Orwoll, ‣ T. Kwok, ‣ M. K. Karlsson, ‣ B. E. Rosengren, ‣ E. Ribom, ‣ P. M. Cawthon, ‣ K. Ensrud, ‣ C. Cooper, ‣ J. A. Kanis, ‣ M. Lorentzon, ‣ C. Ohlsson, ‣ D. Mellström, ‣ H. Johansson, ‣ E. V. McCloskey
11.30
Auditorium A
OC24
‣ RELATIONSHIP BETWEEN THE CHANGES OVER TIME OF BONE AND MUSCLE HEALTH IN CHILDREN AND ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author: ‣ M. Locquet
Authors: ‣ C. Beaudart, ‣ N. Durieux, ‣ J.‑Y. Reginster, ‣ O. Bruyère
11.40
Auditorium A
OC25
‣ BIRTHWEIGHT, LIMB MUSCLE MASS AND GRIP STRENGTH IN MIDDLE AGE: FINDINGS FROM THE UK BIOBANK IMAGING ENHANCEMENT
Presenting author: ‣ E. M.  Curtis
Authors: ‣ J. K. H. Liu, ‣ K. A. Ward, ‣ K. A. Jameson, ‣ Z. Raisi‑Estabragh, ‣ J. Bell, ‣ S. E. Petersen, ‣ C. Cooper, ‣ N. C. Harvey
11.50
Auditorium A
OC26
‣ INTRINSIC CAPACITY AND ITS ASSOCIATION WITH MORTALITY OVER THREE YEARS IN NURSING HOMES: RESULTS OF THE SENIOR COHORT
Presenting author: ‣ A. Charles
Authors: ‣ F. Buckinx, ‣ M. Locquet, ‣ J.‑Y. Reginster, ‣ J. Petermans, ‣ B. Gruslin, ‣ O. Bruyère
12.00
Auditorium A
OC27
‣ DEVELOPMENT AND EXTERNAL VALIDATION OF A PATIENT-LEVEL PREDICTION MODEL FOR 60-DAY MORTALITY FOLLOWING TOTAL KNEE ARTHROPLASTY: A MULTINATIONAL COHORT STUDY
Presenting author: ‣ D. Prieto‑Alhambra
Authors: ‣ A. Bourke, ‣ T. Burkard, ‣ E. Burn, ‣ R. E. Costello, ‣ D. J. Culliford, ‣ A. Delmestri, ‣ T. Duarte‑Salles, ‣ Y. He, ‣ L. H. John, ‣ S. Kolovos, ‣ D. R. Morales, ‣ C. O'Leary, ‣ R. Pinedo‑Villanueva, ‣ A. Prats‑Uribe, ‣ J. Reps, ‣ D. Robinson, ‣ A. G. Sena, ‣ W. Sproviero, ‣ V. Y. Strauss, ‣ R. D. Williams, ‣ B. B. Yimer, ‣ D. Yu, ‣ P. Ryan
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 341
Vitamin D and osteoarthritis
‣ Tim McAlindon
Meeting Room 352A
Disorders of phosphate homeostasis
‣ Maria Luisa Brandi
Meeting Room 353
Fracture Liaison Services: models and fracture risk reduction
‣ Kassim Javaid
Meeting Room 342B
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
‣ Andreas Kurth
14.00 - 15.00
SYMPOSIUM
Meeting Room 342A
Diabetes and Osteoarthritis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: ‣ Elaine M. Dennison, ‣ Marc Hochberg
‣ 14:00: Introduction Roland D. Chapurlat
‣ 14:05: Impact of diabetes mellitus on osteoarthritis incidence and progression Nicola Veronese
‣ 14:20 Management of osteoarthritis in diabetic patients Daniel Uebelhart
‣ 14:35 Discussion André Scheen, Islene Araujo de Carvalho
‣ 14:55 Conclusion Elaine M. Dennison
Panel: ‣ Jaime Branco, ‣ Olivier Bruyère, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Elaine M. Dennison, ‣ Gabriel Herrero‑Beaumont, ‣ Marc Hochberg, ‣ Andrea Laslop, ‣ Emmanuel Maheu, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Roland Roth, ‣ Lucio C. Rovati, ‣ André Scheen, ‣ Daniel Uebelhart, ‣ Nicola Veronese
14.00 - 15.00
Meeting Room 343
Effects of biologics on bone in chronic arthritis
‣ Osvaldo D. Messina
14.00 - 15.00
Poster Area
Poster Viewing Session II
14.00 - 15.03
Podium
Oral presentation of selected posters
Chairperson: ‣ Tara Brennan‑Speranza
14.00
Podium
P433
‣ INFANT FEEDING AND BONE HEALTH IN LATER LIFE: EVIDENCE FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ S. Carter
Authors: ‣ C. Parsons, ‣ S. Robinson, ‣ E. M. Dennison, ‣ C. Cooper
14.07
Podium
P170
‣ DISSCO STUDY: AN INTERNATIONAL, MULTICENTRE, DOUBLE-BLIND, RANDOMISED STUDY ON THE EFFECT OF DIACEREIN VERSUS CELECOXIB ON SYMPTOMS IN KNEE OSTEOARTHRITIS PATIENTS
Presenting author: ‣ J.‑P. Pelletier
Authors: ‣ J.‑P. Raynauld, ‣ P. Paiement, ‣ J. Martel‑Pelletier
14.14
Podium
P542
‣ DEVELOPMENT OF A FRAILTY SPECIFIC PATIENT REPORTED OUTCOME (PRO): THE FRAILQOL
Presenting author: ‣ F. Buckinx
Authors: ‣ C. Beaudart, ‣ J.‑Y. Reginster, ‣ Y. Rolland, ‣ M. Cesari, ‣ R. Rizzoli, ‣ J. Petermans, ‣ O. Bruyère
14.21
Podium
P671
‣ BONE MICROINDENTATION AND TRABECULAR BONE SCORE IDENTIFY PRIOR FRACTURE IN MEN WITH AND WITHOUT CHRONIC KIDNEY DISEASE
Presenting author: ‣ K. L. Holloway‑Kew
Authors: ‣ P. G. Rufus‑Membere, ‣ K. B. Anderson, ‣ M. A. Kotowicz, ‣ A. Diez‑Perez, ‣ N. Hyde, ‣ J. A. Pasco
14.28
Podium
P193
‣ EFFECT OF BISPHOSPHONATE VERSUS MENOPAUSAL HORMONE THERAPY ON FRACTURE RECURRENCE AND MORTALITY AFTER HIP FRACTURE SURGERY IN POSTMENOPAUSAL KOREAN WOMEN: A RANDOMIZED, OPEN-LABEL TRIAL
Presenting author: ‣ S.‑J. Lim
Authors: ‣ C.‑W. Park, ‣ Y.‑S. Park, ‣ S.‑H. Choi, ‣ Y.‑K. Min, ‣ B.‑K. Yoon
14.35
Podium
P466
‣ USING ARTIFICIAL INTELLIGENCE TECHNOLOGY TO IMPROVE CASE FINDING FOR VERTEBRAL FRACTURES IN THE FRACTURE LIAISON SERVICE (FLS) SETTING
Presenting author: ‣ R. Eckert
Authors: ‣ S. Connacher, ‣ R. Mansour, ‣ M. K. Javaid
14.42
Podium
P525
‣ EFFECT OF NUTRITIONAL SUPPLEMENTATIONS ON PHYSICAL PERFORMANCE AND MUSCLE STRENGHT PARAMETERS IN OLDER PEOPLE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author: ‣ N. Veronese
Authors: ‣ P. Soysal, ‣ S. Maggi
14.49
Podium
P458
‣ MEDICAL MANAGEMENT OF ATYPICAL FEMUR FRACTURES: A SYSTEMATIC LITERATURE REVIEW
Presenting author: ‣ D. M. van de Laarschot
Authors: ‣ M. J. Mckenna, ‣ C. Zillikens
14.56
Podium
P319
‣ IMPACT OF POPULATION-BASED OR TARGETED INTERVENTIONS ON FRACTURE INCIDENCE
Presenting author: ‣ N. C. Harvey
Authors: ‣ J. A. Kanis, ‣ E. Liu, ‣ M. Lorentzon, ‣ E. V. McCloskey, ‣ H. Johansson
15.00 - 17.10
Auditorium A
SCIENTIFIC SESSION VI
Chairpersons: ‣ Radmila Matijevic, ‣ Fanny Buckinx
15.00
Auditorium A
Plenary Lecture 7
‣ Tools for estimating fracture probability
‣ John A. Kanis
15.40
Auditorium A
Oral communication selected from abstracts
15.40
Auditorium A
OC28
‣ COMPARISON OF THE PSYCHOMETRIC PROPERTIES OF THE SARQOL® QUESTIONNAIRE WITH THE EWGSOP AND EWGSOP2 CRITERIA FOR SARCOPENIA
Presenting author: ‣ A. Geerinck
Authors: ‣ C. Beaudart, ‣ J.‑Y. Reginster, ‣ O. Bruyère
15.50
Auditorium A
OC29
‣ A POOLED ANALYSIS OF FALL INCIDENCE FROM PLACEBO-CONTROLLED TRIALS OF DENOSUMAB
Presenting author: ‣ E. V. McCloskey
Authors: ‣ R. Eastell, ‣ M. R. McClung, ‣ N. Pannacciulli, ‣ C. Wang, ‣ S. Yue, ‣ S. R. Cummings
16.00
Auditorium A
OC30
‣ IS LOW IMPACT PHYSICAL ACTIVITY ASSOCIATED WITH LOWER LIMB BONE DENSITY AND STRENGTH? RESULTS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ C. Parsons
Authors: ‣ E. M. Dennison, ‣ J. Tobias, ‣ C. Cooper, ‣ K. A. Ward
16.10
Auditorium A
OC31
‣ DIETARY PROTEIN INTAKE AND FALLS IN OLDER PEOPLE: A LONGITUDINAL COHORT STUDY
Presenting author: ‣ N. Veronese
Authors: ‣ P. Soysal, ‣ S. Maggi, ‣ L. Smith
16.20
Auditorium A
OC32
‣ LONGITUDINAL ASSOCIATIONS BETWEEN DIETARY INFLAMMATORY INDEX AND MUSCULOSKELETAL HEALTH IN COMMUNITY-DWELLING OLDER ADULTS
Presenting author: ‣ M. M. Cervo
Authors: ‣ N. Shivappa, ‣ J. Hebert, ‣ W. Oddy, ‣ T. Winzenberg, ‣ S. Balogun, ‣ F. T. Wu, ‣ P. R. Ebeling, ‣ D. Aitken, ‣ G. Jones, ‣ D. Scott
16.30
Auditorium A
OC33
‣ COST-EFFECTIVENESS ASSESSMENT OF DIFFERENT GLUCOSAMINES IN PATIENTS WITH KNEE OSTEOARTHRITIS: A SIMULATION MODEL ADAPTED TO GERMANY
Presenting author: ‣ O. Bruyère
Authors: ‣ J. Detilleux, ‣ J.‑Y. Reginster
16.40
Auditorium A
Plenary Lecture 8
‣ Osteoporosis screening and fracture risk reduction
‣ Cyrus Cooper
Sunday, 7 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 341
Women's special issues: osteoporosis 
Chairperson: ‣ Adriana Orcesi Pedro
‣ Risk factors for osteoporosis: Frax-based intervention and assessment thresholds in Brazil Ben‑Hur Albergaria
‣ Osteoporosis prevention and treatment on special situations during women's reproductive period Adriana Orcesi Pedro
‣ Update on efficacy and safety of post-menopause hormone therapy and fracture prevention Bruno Muzzi Camargos
‣ Question & Answers with audience
Meeting Room 352A
Bone structure in chronic arthritides
Chairpersons: ‣ Osvaldo D. Messina, ‣ Cristiano A. F. Zerbini
‣ Biologic agents and bone loss in rheumatoid arthritis Willem Lems
‣ Non invasive measurement of erosive disease with QCT and MRI in rheumatoid arthritis Jonathan D. Adachi
‣ Value and limitations in HRpQCT imaging in chronic arthritides. Current status and future directions Klaus Engelke
Meeting Room 353
IOF-FFN Joint symposium - Moving from treatment to prevention of new fractures
Chairpersons: ‣ Kristina Åkesson, ‣ Matt Costa
‣ Getting the stars on the map Thierry Thomas
‣ What are the potential uncertainties for trauma surgeons - e.g. fracture healing Andy Gray
‣ The future of surgical fixation in fragile bone Matt Costa
‣ Monitoring patients and tools for getting better Kassim Javaid
‣ Capture the Fracture mentorship programme Donncha O’Gradaigh
Meeting Room 343
Regenerative Medicine in degenerative joint diseases
Chairperson: ‣ George Skarpas
‣ Regenerative Medicine definitions, techniques and joint applications. Where do we stand now? George Skarpas
‣ Guidelines, Theories, Practice and Regulatory mechanisms for Stem Cell Therapy George Samoutis
‣ The role of regenerative medicine in degenerative conditions of the spine. Is there really a role for it? Elias Papadopoulos
‣ Regenerative medicine techniques need specially designed and individualized rehabilitation protocols for optimal results Eirini Kontopoulou
08.00 - 09.00
SYMPOSIA
Meeting Room 342A
New insights in the management of Osteoarthritis: an update of the ESCEO algorithm for the management of the Osteoarthritis
Chairpersons: ‣ François Rannou, ‣ Cyrus Cooper
‣ 08:00 Welcome Cyrus Cooper
‣ 08:05 The 2014-2016 ESCEO Algorithm for the management of the Osteoarthritis Olivier Bruyère
‣ 08:15 New insights in the management of Osteoarthritis Cyrus Cooper
‣ 08:30 The updated ESCEO algorithm for the management of knee Osteoarthritis : Assessment of the various treatment modalities by GRADE Nicola Veronese
‣ 8:55 Discussion Roland Roth
Meeting Room 351
Selection of relevant outcomes in sarcopenia: a Discrete Choice Experiment. Outcomes of an ESCEO consensus meeting
Chairpersons: ‣ Charlotte Beaudart, ‣ Mickaël Hiligsmann
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification and prioritization of important outcomes for patients in sarcopenia Charlotte Beaudart
‣ 08:20: A cross-european discrete choice experiment to assess patients’ preferences for sarcopenia outcomes Mickaël Hiligsmann
‣ 08:40: Discussion Alfonso Cruz Jentoft, Islene Araujo de Carvalho
‣ 08:55: Conclusion Charlotte Beaudart
Panel: ‣ Jürgen Bauer, ‣ Charlotte Beaudart, ‣ Olivier Bruyère, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Mickaël Hiligsmann, ‣ Francesco Landi, ‣ Stefania Maggi, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Yves Rolland
08.00 - 09.00
Meeting Room 342B
ESPRM-ESCEO-IOF Joint Session
WIN - What is new in Physical and Rehabilitation Medicine on Osteoarthritis
Chairpersons: ‣ Fitnat Dincer, ‣ Michael Quittan
‣ W.I.N. - What is new in Hand Osteoarthritis? Update in Physical and Rehabilitation Medicine on Hand Osteoarthritis Fitnat Dincer
‣ W.I.N. - What is new in Knee Osteoarthritis? Update in Physical and Rehabilitation Medicine on Knee Osteoarthritis Michael Quittan
‣ W.I.N - What is New in Hip Osteoarthritis? Update in Physical and Rehabilitation Medicine on Hip Osteoarthritis Raquel Valero
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Meeting Room 341
Androgens: a role in bone and muscle disorders management?
‣ Jean‑Marc Kaufman
Meeting Room 352A
Atypical femoral fracture: stage in 2019
‣ Emmanuel Biver
Meeting Room 353
Pitfalls in identification of vertebral fracture
‣ Christian Roux
Meeting Room 343
Muscle strength/power assessment and outcomes
‣ Olivier Bruyère, ‣ Charlotte Beaudart, ‣ Mylène Aubertin‑Leheudre
Meeting Room 342B
Obesity, bone and muscle
‣ Roland D. Chapurlat
09.00 - 10.00
Poster Area
Poster Viewing Session III
10.00 - 12.00
Auditorium B
SCIENTIFIC SESSION VII
Chairpersons: ‣ Şansın Tüzün, ‣ Famida Jiwa
10.00
Auditorium B
Plenary Lecture 9
‣ Vitamin D: how much is too much?
‣ Bess Dawson‑Hughes
10.40
Auditorium B
Oral communication selected from abstracts
10.40
Auditorium B
OC34
‣ COST-EFFECTIVENESS OF GASTRO-RESISTANT RISEDRONATE TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE
Presenting author: ‣ M. Hiligsmann
Author: ‣ J.‑Y. Reginster
10.50
Auditorium B
OC35
‣ LOCAL OSTEO-ENHANCEMENT PROCEDURE FOR OSTEOPOROTIC BONE LOSS INCREASES RAW TRABECULAR BONE SCORE (R-TBS) IN PROXIMAL FEMURS AT 5-7 YEARS FOLLOW-UP
Presenting author: ‣ C. Lelong
Authors: ‣ J. Stroncek, ‣ J. Howe, ‣ B. Huber, ‣ R. Hill, ‣ D. Hans
11.00
Auditorium B
OC36
‣ EFFECTS OF MUSIC-BASED MULTITASK EXERCISE (JAQUES-DALCROZE EURHYTHMICS) VERSUS MULTICOMPONENT EXERCISE ON PHYSICAL FUNCTION, FALLS AND BRAIN PLASTICITY IN OLDER ADULTS: A RANDOMIZED CONTROLLED TRIAL
Presenting author: ‣ A. Trombetti
Authors: ‣ M. Hars, ‣ N. Fernandez, ‣ F. Herrmann, ‣ R. Rizzoli, ‣ G. Gold, ‣ P. Vuilleumier
11.10
Auditorium B
OC37
‣ RESULTS FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
Presenting author: ‣ T. McAlindon
Authors: ‣ Y. Yazici, ‣ J. Tambiah, ‣ A. Gibofsky, ‣ N. Lane, ‣ C. Lattermann, ‣ N. Skrepnik, ‣ C. Swearingen, ‣ A. Difrancesco, ‣ M. Hochberg
11.20
Auditorium B
OC38
‣ LONG TERM RATES OF CHANGE IN MUSCULOSKELETAL AGING: FINDINGS FROM THE HEALTH, AGING AND BODY COMPOSITION STUDY
Presenting author: ‣ L. D. Westbury
Authors: ‣ H. E. Syddall, ‣ E. M. Dennison, ‣ J. Cauley, ‣ T. B. Harris, ‣ E. J. Shiroma, ‣ B. H. Goodpaster, ‣ A. B.  Newman, ‣ C. Cooper
11.30
Auditorium B
Plenary Lecture 10
‣ Dietary protein, dairy and bone: devils or angels?
‣ René Rizzoli
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Meeting Room 341
Approach to Osteoporotic Hip Fractures
Chairpersons: ‣ Berrin Durmaz, ‣ Sema Oncel
‣ Osteoporotic Hip Fractures: Are we able to prevent? Yesim Kirazli
‣ Pharmacological Treatment after Hip Fractures: When and How? Ozlem El
‣ Adherence to Pharmacological Treatment of Osteoporosis Yesim Gokce Kutsal
‣ Rehabilitation after Hip Fractures Funda Calis
‣ Prevention of Complications Following Hip Fractures Ozlen Peker
Meeting Room 352A
Osteonecrosis of the jaw management in the clinical setting
Chairperson: ‣ Bruno Muzzi Camargos
‣ Pathophysiology and Risk Factors Oscar Rosero Olarte
‣ Biochemical markers and Imaging use on ONJ Bruno Muzzi Camargos
‣ Osteosteoporosis Therapies and ONJ. Adriana Medina Orjuella
‣ Clinical scenarios #1: Oral invasive procedures pre-op patients Monique Chalem
‣ Clinical scenarios #2: Oral invasive procedures pre-op patients Ana Karina Sarmiento Lievano
Meeting Room 343
Osteoarthritis and vascular aging
Chairperson: ‣ Sekib Sokolovic
‣ Introduction Sekib Sokolovic
‣ The impact of osteoarthritis on aging Sansin Tüzün
‣ The crosstalk between vessels, bone and cartilage: does it exist Marius Miglinas
‣ Osteaorthritis and vascular aging Sekib Sokolovic
Meeting Room 342B
Exercice with or without nutrition as countermeasures of dynapenia in older adults
Chairpersons: ‣ Bertrand Fougère, ‣ Fanny Buckinx, ‣ Mylène Aubertin‑Leheudre
‣ How to maintain muscle quality: the secret of a successful aging Bertrand Fougère
‣ Exercise to prevent muscle function in dynapenic or non-dynapenic older adults: one fits for all? Mylène Aubertin‑Leheudre
‣ Impact of nutrition during exercise intervention on muscle adaptation in older adults Fanny Buckinx